SOLUM Receives Two Red Dot Product Design Awards for Shelf-Edge and In-Store Communication Solutions
15.4.2026 11:20:00 EEST | Business Wire | Press release
SOLUM (KOSPI: 248070) has received the Red Dot Award: Product Design for Newton Core+ and Newton E-Paper 32”, with both products recognised for addressing core retail requirements across function, design quality, ease of use, and responsibility.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260415714608/en/
Red Dot Product Design Awards 2026 highlight Newton Core+ and Newton E-Paper 32” (Image: SOLUM)
As retailers place greater emphasis on solutions that support store presentation, operational usability, and long-term reliability, the awards highlight two products developed around those priorities. Newton Core+ and Newton E-Paper 32” reflect a retail technology approach shaped by the practical demands of the store environment, where visual consistency, day-to-day usability, and dependable performance all matter.
Newton Core+: Premium Shelf-Edge Design Must Also Withstand Daily Retail Use
For Newton Core+, the recognition highlights a product designed to raise the standard of the everyday Electronic Shelf Label (ESL). In retail, the shelf edge is becoming a more visible element of store design, and ESLs are increasingly expected to combine ease of use with the durability required for daily operations.
Newton Core+ addresses that need by combining a slimmer, more refined shelf presentation with the resilience required for daily operations. Its slim profile and narrow bezel contribute to a cleaner, more consistent appearance, while the anti-glare front surface supports clear readability under different lighting conditions. Its protective window structure further helps the label withstand contact and impact in demanding store conditions. The result is a product that supports both shelf-edge quality and reliable large-scale deployment.
Newton E‑Paper 32”: Moving Large-Format Store Communication Beyond Paper
For Newton E-Paper 32”, the award recognises a product designed to offer retailers a more flexible and sustainable alternative to paper-based large-format communication. In-store paper signage often involves repeated printing, replacement, and disposal, while Newton E-Paper 32” is designed to reduce that burden through ultra-low power operation and battery-powered use.
At 16.4 mm in depth and 2.3 kg in weight, the display is designed for easier integration across a wide range of retail settings. Installation options, including suction, hanging, VESA mounting, and easel use, support different layouts and communication needs, while the bottom-positioned slide-in battery pack helps simplify maintenance, including in elevated installations. Supporting up to 400 days¹ of use with one update per day, Newton E-Paper 32” offers retailers a practical way to move beyond paper with greater flexibility and lower ongoing complexity.
Better product design is becoming a rollout requirement in retail
As retailers expand the shift from paper-based communication to more connected store environments, in-store technologies are increasingly expected to deliver usability, visual quality, durability, and sustainability. Newton Core+ and Newton E-Paper 32” reflect that direction and support SOLUM’s broader role as a retail digital transformation partner.
“SOLUM supports retailers through a broad portfolio of solutions and partnerships, while continuing to strengthen product competitiveness through strong R&D capabilities,” said Boyle Seo, EVP, Head of ESL Solution Business Division at SOLUM. “These awards reflect that strength, and we will continue advancing our product foundation in step with the next phase of retail transformation.”
¹ Results are based on internal testing and may vary depending on conditions and usage scenarios.
About SOLUM
Founded in 2015 as a spin-off from Samsung Electro-Mechanics, SOLUM is a publicly traded company listed on the KOSPI stock exchange. The company has established itself as a leader in power solutions, display technologies, and electronic shelf labels (ESL), driving innovation across the global retail sector. With a strong commitment to customer-centric innovation and sustainable retail transformation, SOLUM continues to develop high-quality solutions that empower retailers to operate more efficiently in an increasing digital world.
Learn more at www.solum-group.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20260415714608/en/
Contacts
SOLUM Europe GmbH
Jiyoo Hwang
Jiyoo.hwang@solum-group.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
www.businesswire.com

Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Barilla Opens Global Call for Startups Through Good Food Makers 202625.5.2026 12:47:00 EEST | Press release
Barilla Group has opened applications for the 2026 edition of Good Food Makers, its global open innovation program designed to co-develop and test new innovative solutions with startups and innovators inside real industrial environments. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521973445/en/ Since its launch in 2019, the program has involved more than 1,100 startups from over 50 countries, leading to 26 pilot projects, with over 20 projects currently active thanks to the solutions developed by the program’s alumni. This highlights the program’s role as a concrete platform for industrial scalable innovation. The 2026 edition comes at a pivotal moment for the company, following the launch of BITE (Barilla Innovation & Technology Experience), the new innovation center dedicated to developing the next generation of food products. Within this inspiring premise, Good Food Makers confirms itself as one of the main levers f
JEOL: Sales Launch of the Laser SEM System “LazEdge”25.5.2026 11:16:00 EEST | Press release
JEOL Ltd. (President & CEO: Izumi Oi) has developed the “LazEdge”, an SEM system equipped with a laser processing system, and begins sales on May 25, 2026. Cross-section preparation instruments such as the focused ion beam system (FIB system), are widely used in science and technology fields across research institutes, universities, and industries. In recent years, demand is increasing for a system that can process large-areas at a high speed, while achieving high-quality of the processed surface. “LazEdge” is an instrument integrating JEOL’s SEM with the laser technology proprietary of Hamamatsu Photonics K.K., and enables laser processing inside the specimen chamber of the electron microscope. This system enables high-quality cross-section specimens produced through high-speed, large-area processing to be transferred seamlessly to subsequent analyses, such as SEM observation, elemental analysis, and crystal orientation analysis, without exposure to the external environment. As a resu
TFG-001, A Novel 3D Neural Microtissue Cell Therapy, Demonstrates Superior Functionality and Reinnervation for Parkinson’s Disease25.5.2026 09:00:00 EEST | Press release
TreeFrog Therapeutics, a regenerative medicine biotech company developing next-generation cell therapies, today announced that it will present new preclinical data on TFG-001 at the 7th World Parkinson’s Conference. TFG-001, a 3D neural microtissue cell therapy, demonstrated rapid dopamine release and extensive graft-derived reinnervation across multiple advanced translational Parkinson’s disease models—supporting its potential as a best-in-class candidate. The critical need for reinnervation in Parkinson's disease In Parkinson's disease, an estimated 60–80% of dopaminergic neurons are already lost before motor symptoms even appear. The nigrostriatal pathway degenerates, destroying the essential wiring that connects dopamine-producing neurons to movement control. While chemical dopamine replacements (like levodopa) can manage symptoms, they cannot restore the spatial precision, feedback loops, or dynamic regulation of a healthy brain network. To achieve true functional restoration, it
TFG-001, A Novel 3D Neural Microtissue Cell Therapy, Demonstrates Superior Functionality and Reinnervation for Parkinson’s Disease25.5.2026 09:00:00 EEST | Press release
TreeFrog Therapeutics, a regenerative medicine biotech company developing next-generation cell therapies, today announced that it will present new preclinical data on TFG-001 at the 7th World Parkinson’s Conference. TFG-001, a 3D neural microtissue cell therapy, demonstrated rapid dopamine release and extensive graft-derived reinnervation across multiple advanced translational Parkinson’s disease models—supporting its potential as a best-in-class candidate. The critical need for reinnervation in Parkinson's disease In Parkinson's disease, an estimated 60–80% of dopaminergic neurons are already lost before motor symptoms even appear. The nigrostriatal pathway degenerates, destroying the essential wiring that connects dopamine-producing neurons to movement control. While chemical dopamine replacements (like levodopa) can manage symptoms, they cannot restore the spatial precision, feedback loops, or dynamic regulation of a healthy brain network. To achieve true functional restoration, it
Galderma Receives U.S. FDA Approval for Differin ® Epiduo ® Acne Gel Prescription-to-OTC Switch22.5.2026 19:25:00 EEST | Press release
Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) use in ages 12 years and older, marking a significant Prescription-to-OTC transition in acne care. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260522074280/en/ The U.S. FDA approves Differin® Epiduo® Acne Gel Prescription-to-OTC switch This milestone represents yet another example of Galderma’s unique Integrated Dermatology strategy, demonstrating how proven innovations from its Therapeutic Dermatology portfolio can further strengthen its Dermatological Skincare offerings. The Prescription‑to‑OTC transition highlights Galderma’s scale and expertise in successfully commercializing dermatology innovations across the full spectrum of acne care. With the appro
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom